PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer

被引：0
|
作者：
Antonia, S. J. [1 ]
Villegas, A. [2 ]
Daniel, D. [3 ,4 ]
Baz, D. Vincente [5 ]
Murakami, S. [6 ]
Hui, R. [7 ,8 ]
Yokoi, T. [9 ]
Chiappori, A. [1 ]
Lee, K. H. [10 ]
de Wit, M. [11 ]
Cho, B. C. [12 ]
Bourhaba, M. [13 ]
Quantin, X. [14 ,15 ]
Tokito, T. [16 ]
Mekhail, T. [17 ]
Planchard, D. [18 ]
Jiang, H. [19 ]
Huang, Y. [19 ]
Dennis, P. A. [19 ]
Ozguroglu, M. [20 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Canc Specialists North Florida, Jacksonville, FL USA
[3] Tennessee Oncol, Chattanooga, TN USA
[4] Sarah Cannon Res Inst, Nashville, TN USA
[5] Hosp Univ Virgen Macarena, Seville, Spain
[6] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan
[7] Westmead Hosp, Sydney, NSW, Australia
[8] Univ Sydney, Sydney, NSW, Australia
[9] Kansai Med Univ Hosp, Hirakata, Osaka, Japan
[10] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Coll Med, Cheongju, South Korea
[11] Vivantes Klinikum Neukoelln, Berlin, Germany
[12] Yonsei Univ, Yonsei Canc Ctr, Coll Med, Seoul, South Korea
[13] Ctr Hosp Univ Liege, Liege, Belgium
[14] CHU Montpellier, Montpellier, France
[15] ICM Val dAurelle, Montpellier, France
[16] Kurume Univ Hosp, Kurume, Fukuoka, Japan
[17] Florida Hosp, Inst Canc, Orlando, FL USA
[18] Gustave Roussy, Villejuif, France
[19] AstraZeneca, Gaithersburg, MD USA
[20] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 05期
关键词：
D O I：
10.1016/j.ijrobp.2017.09.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA-4
引用
收藏
页码：1314 / 1315
页数：4
相关论文
共 50 条
  • [21] Consolidation Treatment of Durvalumab After Chemoradiation in the Real World Patients of Stage Three Unresectable Non-Small Cell Lung Cancer: The Preliminary Result
    Ju, J.
    Huang, A.
    Wang, C.
    Chang, W.
    Kuo, C.
    Yang, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [22] Impact of radiation on host immune system in patients treated with chemoradiotherapy and durvalumab consolidation for unresectable locally advanced non-small cell lung cancer
    Pasquier, Corentin
    Chaltiel, Leonor
    Massabeau, Carole
    Rabeau, Audrey
    Lebas, Louisiane
    Lusque, Amelie
    Texier, Jean-Sebastien
    Moyal, Elizabeth Cohen-Jonathan
    Mazieres, Julien
    Khalifa, Jonathan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study
    Wang, Chin-Chou
    Chiu, Li-Chung
    Ju, Jia-Shiuan
    Lin, Yu-Ching
    Fang, Yueh-Fu
    Yang, Cheng-Ta
    Hsu, Ping-Chih
    VACCINES, 2021, 9 (10)
  • [24] Vitamin D Supplementation and Survival of Patients with Non-small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
    Akiba, Tadashi
    Morikawa, Toshiaki
    Odaka, Makoto
    Nakada, Takeo
    Kamiya, Noriki
    Yamashita, Makoto
    Yabe, Mitsuo
    Inagaki, Takuya
    Asano, Hisatoshi
    Mori, Shohei
    Tsukamoto, Yo
    Urashima, Mitsuyoshi
    CLINICAL CANCER RESEARCH, 2018, 24 (17) : 4089 - 4097
  • [25] Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung cancer
    Ready, NE
    Vokes, EE
    LUNG CANCER, 2003, 42 : S65 - S69
  • [26] A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC).
    Hoffman, PC
    Mauer, AM
    Haraf, DC
    Lester, EP
    Szeto, LL
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 648S - 648S
  • [27] Randomized, Double-Blind, Placebo-Controlled Phase II Study of Single-Agent Oral Talactoferrin in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer That Progressed After Chemotherapy
    Parikh, Purvish M.
    Vaid, Ashok
    Advani, Suresh H.
    Digumarti, Raghunadharao
    Madhavan, Jayaprakash
    Nag, Shona
    Bapna, Ajay
    Sekhon, Jagdev S.
    Patil, Shekhar
    Ismail, Preeti M.
    Wang, Yenyun
    Varadhachary, Atul
    Zhu, Junming
    Malik, Rajesh
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4129 - 4136
  • [28] Concurrent durvalumab plus chemoradiation therapy followed by durvalumab in Chinese patients with unresectable stage III non-small cell lung cancer: CRUISER study
    Teng, Feifei
    Ge, Hong
    Wang, Buhai
    Xu, Yaping
    Meng, Xue
    Wang, Suzhen
    Xing, Ligang
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Identification of predictive factors for early relapse in patients with unresectable stage III non-small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy
    Nam, Jung Hyun
    Yeo, Chang Dong
    Park, Chan Kwon
    Kim, Sung Kyoung
    Kim, Ju Sang
    Kim, Yong Hyun
    Kim, Jin Woo
    Kim, Seung Joon
    Lee, Sang Haak
    Kang, Hye Seon
    THORACIC CANCER, 2023, 14 (26) : 2657 - 2664
  • [30] Durvalumab Consolidation Following Chemoradiation for Unresectable Non-Small Cell Lung Cancer: A "Real-World" Experience.
    Griffiths, C.
    Menon, S.
    Thompson, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S366 - S367
12345